Farnesoid X receptor is essential for normal glucose homeostasis.
By Ke Ma, P. Saha, L. Chan, D. Moore. Journal of Clinical Investigation, 2006
845 citations recorded by the source corpus.
Subfields: Epidemiology, Molecular Biology, Oncology
View Paper: https://www.semanticscholar.org/paper/222d50fae244f64b33293e8021d742e629ff1099
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Epidemiology
In Molecular Biology
In Oncology
Citations in the corpus
- Impaired regulation of hepatic glucose production in mice lacking the forkhead transcription factor Foxo1 in liver. (2007, background): “In this regard, residual HGP in Foxo1-deficient liver likely reflects the contribution of Foxo3 to this process, or that mediated by c/Ebpa (Wang et al., 1995), NR4 (Pei et al., 2006), STAT3 (Inoue et al., 2004), Fxr (Ma et al., 2006), and Foxa2 (Zhang et al., 2005).”
- Role of bile acids and bile acid receptors in metabolic regulation. (2009, background): “However, in vivo studies clearly demonstrate that mice with a 95% reduction in PEPCK mRNA have a nearly normal blood glucose concentration after a 24-h fast (279, 280).”
- Bile Acid Metabolism and Signaling (2013, neutral): “Accumulation of toxic endobiotics xenobiotics causes damage to cells and organs in the tract.”
- Bile Acid Signaling in Metabolic Disease and Drug Therapy (2014, background): “Fxr knockout mice had elevated circulating and muscle free fatty acids, which explains the peripheral insulin-resistant phenotype observed in these mice (Ma et al., 2006).”
- Pleiotropic Roles of Bile Acids in Metabolism (2013, methodology): “The earlier finding that Fxr–/– mice are insulin resistant 662 Cell Metabolism 17, May 7, 2013 ª2013 Elsevier Inc. suggested a role for FXR in glucose metabolism (Cariou et al., 2006; Ma et al., 2006; Zhang et al., 2006).”
- TGR5-mediated bile acid sensing controls glucose homeostasis. (2009, background): “Instead, FXR-mediated actions of BAs appear mainly to affect liver metabolism by increasing glycogen production (Duran-Sandoval et al., 2005; Ma et al., 2006; Zhang et al., 2006) and decreasing lipogenesis and VLDL production (Watanabe et al.”
- Transcriptional integration of metabolism by the nuclear sterol-activated receptors LXR and FXR (2012, background): “Moreover, decreased plasma glucose levels with a concomitant attenuation in gluconeogenic genes was observed when FXR was activated by cholic acid in wild-type but not in Fxr -null mic”
- Targeting bile-acid signalling for metabolic diseases (2008, background): “Bile acids have been reported to inhibit gluconeogenesis via the downregulation of phosphoenolpyruvate carboxykinase ( PEPCK ) mRNA levels both in an FXR-α-dependent and FXR-α-independent manne”